My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

SciSparc Ltd. - Ordinary Shares (NQ:SPRC)

0.6508 -0.0332 (-4.85%)

Streaming Delayed Price Updated: 3:04 PM EST, Feb 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about SciSparc Ltd. - Ordinary Shares

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

SciSparc Gains Competitive Edge with Additional U.S. Patent Granted

November 08, 2022

From SciSparc Ltd

Via GlobeNewswire

Study Shows Positive Results In Patients With Alzheimer's Disease And Agitation ↗

November 07, 2022

SciSparc Ltd. (NASDAQ: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system announced positive interim...

Via Benzinga

SciSparc Announced Positive Interim Results Meeting Primary Endpoints at Phase IIa Study in Alzheimer’s Disease Patients with Agitation

November 07, 2022

From SciSparc Ltd

Via GlobeNewswire

Why FAT Brands Shares Are Trading Sharply Lower; Here Are 24 Stocks Moving Premarket ↗

November 07, 2022

Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) shares rose 39.5% to $24.39 in pre-market trading following recent reports that Donald Trump could soon announce 2024 Presidential run.

Via Benzinga

Why Is SciSparc (SPRC) Stock Up 50% Today? ↗

September 14, 2022

SPRC stock is catapulting higher this morning as traders catch wind of SciSparc's intent to acquire a top niche product seller on Amazon.

Via InvestorPlace

SciSparc Nutraceuticals Signs Agreement With Logistics Facilities, Expected To Optimize Handling and Shipment Processes and Reduce Direct Sales Costs ↗

November 02, 2022

SciSparc Ltd. (NASDAQ: SPRC) announced that SciSparc Nutraceuticals Inc., its wholly owned subsidiary, has signed an agreement with logistics facilities in New Jersey, U.S. as part of SciSparc...

Via Benzinga

SciSparc: Wellution™ Signs an Agreement with Logistics Facilities in New Jersey to Supports its Expansion to Additional e-Commerce Platforms

November 01, 2022

From SciSparc Ltd

Via GlobeNewswire

SciSparc: Wellution™ Successfully Launched a New Keto Gummies Apple Cider Vinegar Product and Generated $100,000 In Revenues Within 30 Days

October 28, 2022

From SciSparc Ltd

Via GlobeNewswire

SciSparc Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification

October 12, 2022

From SciSparc Ltd

Via GlobeNewswire

SciSparc Acquires Top Seller On Amazon, Wellution, For $20M ↗

September 30, 2022

SciSparc Ltd. (NASDAQ: SPRC) closed the definitive agreements for its acquisition of Wellution, an Amazon.com Marketplace account, American food supplements and cosmetics brand and trademark.

Via Benzinga

SciSparc Completes the Acquisition of Wellution™, Top Seller of American Food Supplements and Cosmetics Brand on Amazon, for $20 million

September 30, 2022

From SciSparc Ltd

Via GlobeNewswire

SciSparc And Clearmind Partnership Yields 3rd Patent Application For The Treating Of Obesity And Metabolic Syndromes ↗

September 22, 2022

SciSparc Ltd. (NASDAQ: SPRC) announced that Clearmind Medicine Inc. (OTCPK:CMNDF) (CSE:CMND) (FSE:CWY0), has filed a provisional patent application related to metabolic syndromes including obesity,...

Via Benzinga

Dow, S&P 500 Turn Lower; Altimmune Shares Slide ↗

September 14, 2022

U.S. stocks pared gains toward the end of trading, with the Dow Jones dropping around 80 points on Wednesday.

Via Benzinga

CFVI Stock Heats Up Ahead of Rumble SPAC Merger Vote ↗

September 14, 2022

CF Acquisition (CFVI) stock is getting a boost on Wednesday as investors prepare to vote on a SPAC merger with Rumble tomorrow.

Via InvestorPlace

Why ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From Yesterday ↗

September 16, 2022

Gainers

Via Benzinga

Nasdaq Surges 100 Points; Crude Oil Rises 2% ↗

September 14, 2022

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Wednesday.

Via Benzinga

Why Adobe Is Trading Lower By 17%, Here Are 49 Stocks Moving In Thursday's Mid-Day Session ↗

September 15, 2022

Gainers HeartBeam, Inc. (NASDAQ: BEAT) shares surged 58% to $1.96 after the company announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome...

Via Benzinga

SciSparc To Acquire Top Amazon Seller: Why SPRC Shares Are Soaring Today ↗

September 14, 2022

SciSparc Ltd (NASDAQ: SPRC) shares are trading higher Wednesday after the company announced it entered into an agreement to acquire Wellution for $20 million.

Via Benzinga

SciSparc To Acquire One Of Top Sellers Of Food Supplements, Cosmetics And Hemp-Based Products On Amazon ↗

September 14, 2022

SciSparc Ltd. (NASDAQ: SPRC) signed a definitive agreement with Merhavit M.R.M Holding and Management Ltd (“M.R.M”), to acquire its rights to purchase, Wellution, an Amazon.com (NASDAQ:

Via Benzinga

Why Vintage Wine Estates Shares Tumbled 40%; Here Are 70 Biggest Movers From Yesterday ↗

September 15, 2022

Gainers AMTD Digital Inc. (NYSE: HKD) shares jumped 311.8% to settle at $189.42 on Wednesday as the stock experienced a resurgence in momentum despite a lack of fundamental news.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

September 02, 2022

On Friday, 122 stocks hit new 52-week lows.

Via Benzinga

Why SciSparc Is Trading Higher By 68%, Here Are 48 Stocks Moving In Wednesday's Mid-Day Session ↗

September 14, 2022

Gainers Akerna Corp. (NASDAQ: KERN) shares rose 81.2% to $0.2355 after gaining 8% on Tuesday.

Via Benzinga

Additional Positive Results Revealed In Cocaine Addiction Treatment Through SciSparc-Clearmind Collaboration ↗

August 25, 2022

SciSparc Ltd. (NASDAQ: SPRC) recently announced additional positive pre-clinical results of its Psychedelic-based Pharma Collaboration for treatment for cocaine addiction using MEAI, a novel...

Via Benzinga

SciSparc Ltd. Announces Additional Positive Results for the Cocaine Addiction Treatment of its Psychedelic-based Pharma Collaboration with Clearmind Medicine Inc. ↗

August 25, 2022

Results indicate significant decrease in cocaine craving in a sub-group that received the treatment

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

August 30, 2022

On Tuesday, 250 stocks hit new 52-week lows.

Via Benzinga

Why Minerva Neurosciences Shares Traded Higher By Over 66%; Here Are 78 Biggest Movers From Yesterday ↗

August 25, 2022

Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) shares gained 66.5% to close at $7.51 after Point72 Asset Management reported an 8.8% passive stake in the company.

Via Benzinga

Psychedelic-Based Cocaine Addiction Treatment Study Showing Positive Results. This Is What We Know ↗

August 24, 2022

Israeli-Canadian biotech psychedelics developer Clearmind Medicine Inc. (OTC Pink: CMNDF) together with clinical-stage cannabinoid pharma company SciSparc Ltd.

Via Benzinga

Why Are Psychedelics Stocks Up Today? ↗

August 24, 2022

Shares of SEEL stock are in the green after the company received a grant from the Michael J. Fox Foundation to advance its SLS-004 candidate.

Via InvestorPlace

S&P 500 Edges Higher; Nordstrom Shares Plummet ↗

August 24, 2022

U.S. stocks traded slightly higher toward the end of trading, with the Nasdaq Composite gaining around 50 points on Wednesday.

Via Benzinga

Why Citi Trends Is Trading Lower By 17%, Here Are 47 Stocks Moving In Wednesday's Mid-Day Session ↗

August 24, 2022

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 77% to $2.35. Bright Minds priced overnight marketed offering of 2.858 million units at $1.40 per unit.

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.